Peripheral | Search Results | Leaders in Pharmaceutical Business Intelligence (LPBI) Group

Search Results for 'Peripheral'

CNS immune interface

Posted in Ca2+ triggered activation, Calmodulin, Neurodegenerative Diseases, Neurohumoral Transmission, Neurological Diseases, Neuroscience, Pain: Etiology, Genetics & Innovations in Treatment, Synaptic vesicle, tagged calcitonin gene-related peptide (CGRP), CNS and PNS, CNS immune interface, GABAergic, glycinergic inhibitory interneurons, glycinergic inhibitory interneurons., γ-aminobutyric acid, kainate receptors, Neuroimmunology on August 9, 2021| Leave a Comment »

CNS immune interface Reporter: Komal Ingle, BSc, MSc Neuroimmunology is a field that investigates the bi-directional communication between the nervous system (CNS and PNS) and the immune system. While these two physiological systems were traditionally thought to act independently and that the brain was a privileged site protected by the blood–brain barrier (BBB), researchers now […]

Read Full Post »

Bioresorbable Stent Clinical Trials with New Esprit Below-the-knee Scaffold

Posted in Cardiac and Cardiovascular Surgical Procedures, Medical Devices R&D and Inventions, Peripheral Arterial Disease & Peripheral Vascular Surgery, Stents & Tools, tagged biodegradable scaffold, Clinical Trials, critical limb ischemia (CLI), Esprit BTK System, everolimus on October 9, 2020| Leave a Comment »

Bioresorbable Stent Clinical Trials with New Esprit Below-the-knee Scaffold Reporter: Irina Robu, PhD Abbott announced on September 3, 2020, the beginning of the LIFE-BTK clinical trial to evaluate effectiveness and safety of the Esprit BTK Everolimus Eluting Resorbable Scaffold System. The Esprit BTK System consists of a thin strutted scaffold made of poly-L-lactide, a semi-crystalline […]

Read Full Post »

The Golden Hour of Stroke Intervention

Posted in Peripheral Arterial Disease & Peripheral Vascular Surgery, tagged Artery, endovascular thrombectomy, Statistics, surgery, Thrombus on March 5, 2019| 1 Comment »

The Golden Hour of Stroke Intervention Reporter: Irina Robu, PhD The removal of thrombus under the image guidance, endovascular thrombectomy is preferred for an arterial embolism which is characteristic for an arterial blockage frequently caused by atrial fibrillation, a heart rhythm disorder. An arterial embolism causes restricted blood supply which leads to pain in the […]

Read Full Post »

Targeting Atherosclerotic Plaques with Stents made of Drug-eluting Biomaterials

Posted in Biodegradable Drug-eluting Material, Bioresorbable Vascular Scaffold (BVS), Cardiac and Cardiovascular Surgical Procedures, Frontiers in Cardiology and Cardiovascular Disorders, PCI, Peripheral Arterial Disease & Peripheral Vascular Surgery, Stents & Tools, Vascular Diseases on June 9, 2020| Leave a Comment »

Targeting Atherosclerotic Plaques with Stents made of Drug-eluting Biomaterials Reporter: Daniel Menzin, BSc BioMedical Engineering, expected, May 2021, Research Assistant 4, Core Applications Developer and Acting CTO Atherosclerosis is a chronic cardiovascular disease with a multitude of different implications. A coronary artery plaque may lead to congestive heart failure while an aortic plaque may […]

Read Full Post »

First single-course ‘curative’ CRISPR Shot by Intellia rivals Alnylam, Ionis and Pfizer

Posted in Biological Networks, Gene Regulation and Evolution, Cardiomyopathy, Cell Biology, Cerebrovascular and Neurodegenerative Diseases, Chemical Biology and its relations to Metabolic Disease, Chemical Genetics, CRISPR alternative for editing genes without cutting, CRISPR/Cas9 & Gene Editing, Frontiers in Cardiology and Cardiovascular Disorders, Genetics & Pharmaceutical, Genome Biology, Liver & Digestive Diseases Research, Population Health Management, Genetics & Pharmaceutical, Proteomics, RNA interference (RNAi) therapeutic, tagged polyneuropathy on February 19, 2021| Leave a Comment »

First single-course ‘curative’ CRISPR Shot by Intellia rivals Alnylam, Ionis and Pfizer Reporter: Aviva Lev-Ari, PhD, RN Intellia to kick-start first single-course ‘curative’ CRISPR shot, as it hopes to beat rivals Alnylam, Ionis and Pfizer by Ben Adams | Oct 19, 2020 10:39am It’s been a good year for Intellia: One of its founders, Jennifer Doudna, […]

Read Full Post »

The Role of Cholesterol Crystals in increase of NLRP3 Inflammasome affecting Coronary Artery Disease & Carotid Atherosclerosis

Posted in Atherogenic Processes & Pathology, Frontiers in Cardiology and Cardiovascular Disorders, Origins of Cardiovascular Disease, Systemic Inflammatory Diseases as CVD Risk, Vascular Diseases on September 15, 2020| Leave a Comment »

The Role of Cholesterol Crystals in increase of NLRP3 Inflammasome affecting Coronary Artery Disease & Carotid Atherosclerosis Reporters: Justin D. Pearlman, MD, PhD, FACC and Aviva Lev-Ari, PhD, RN The Voice of Dr. Justin D. Pearlman, MD, PhD, FACC Justin D. Pearlman, MD, PhD, FACC – Scientific Expert & Key Opinion Leader on Cardiovascular Diseases, […]

Read Full Post »

Puntos de vista acerca del óxido nítrico en los mecanismos patogénicos

Posted in on June 6, 2022|

View on Amazon.com https://www.amazon.com/dp/B0BPST4B4N Audio y Texto NEW GENRE Volume One: Perspectives on Nitric Oxide in Disease Mechanisms – Series A: Volume 1 | Leaders in Pharmaceutical Business Intelligence (LPBI) Group https://pharmaceuticalintelligence.com/audio-english-spanish-biomed-e-series/new-genre-audio-english-spanish-series-a-e-books-on-cardiovascular-diseases/new-genre-volume-one-perspectives-on-nitric-oxide-in-disease-mechanisms-series-a-volume-1/ Original Volume One: Perspectives on Nitric Oxide in Disease Mechanisms NEW GENRE Volume One: Perspectives on Nitric Oxide in Disease Mechanisms https://pharmaceuticalintelligence.com/audio-english-spanish-biomed-e-series/new-genre-audio-english-spanish-series-a-e-books-on-cardiovascular-diseases/new-genre-volume-one-perspectives-on-nitric-oxide-in-disease-mechanisms-series-a-volume-1/ […]

Read Full Post »

Risks from Dual Antiplatelet Therapy (DAPT) may be reduced by Genotyping Guidance of Cardiac Patients

Posted in CABG, Cardiac and Cardiovascular Surgical Procedures, Frontiers in Cardiology and Cardiovascular Disorders, Genetics & Innovations in Treatment, Genetics & Pharmaceutical, Genome Biology, PCI, Peripheral Arterial Disease & Peripheral Vascular Surgery, Pharmacotherapy of Cardiovascular Disease, Stroke on November 20, 2019| Leave a Comment »

Risks from Dual Antiplatelet Therapy (DAPT) may be reduced by Genotyping Guidance of Cardiac Patients Reporter: Aviva Lev-Ari, PhD, RN Genotyping Cardiac Patients May Reduce Risks From DAPT -STEMI patient study reaches noninferiority mark for adverse cardiac events by Vicki Brower, CME Writer, MedPage Today September 7, 2019 In the investigational arm, all 1,242 patients were tested […]

Read Full Post »

Parasym™ neuromodulation device reveals promising developments in the treatment of heart failure patients with preserved ejection fraction: Clinical Trial Results

Posted in Cardiovascular Research, Electrophysiology, Frontiers in Cardiology and Cardiovascular Disorders, Heart Failure (HF), Medical Devices R&D and Inventions on February 22, 2022| Leave a Comment »

Parasym™ neuromodulation device reveals promising developments in the treatment of heart failure patients with preserved ejection fraction: Clinical Trial Results Reporter and Curator: Aviva Lev-Ari, PhD, RN Neuromodulation of Inflammation to Treat Heart Failure With Preserved Ejection Fraction: A Pilot Randomized Clinical Trial Stavros Stavrakis, Khaled Elkholey, Lynsie Morris, Monika Niewiadomska, Zain Ul Abideen […]

Read Full Post »

New Etiology for COVID-19: Death results from Immune-Mediation (virus-independent immunopathology: lung and reticuloendothelial system) vs Pathogen-Mediation causing Organ Dysfunction & Hyper-Inflammation – Immunomodulatory Therapeutic Approaches (dexamethasone)

Posted in COVID-19, Immune-Mediation (independent immunopathology: lung and reticuloendothelial system), Population Health Management, Genetics & Pharmaceutical, SARS-CoV-2, Serology tests for coronavirus antibodies, Treatment Protocols for COVID-19, Virus Infective Acute Respiratory Syndrome: SARS-CoV on July 12, 2020| Leave a Comment »

New Etiology for COVID-19: Death results from Immune-Mediation (virus-independent immunopathology: lung and reticuloendothelial system) vs Pathogen-Mediation causing Organ Dysfunction & Hyper-Inflammation – Immunomodulatory Therapeutic Approaches (dexamethasone) Curators: Stephen J. Williams and Aviva Lev-Ari, PhD, RN State of Science on 7/21/2020 New Etiology for COVID-19: Death results from Immune-Mediation (virus-independent immunopathology: lung and reticuloendothelial system) […]